Rafael Pharmaceuticals
Cranbury
About Rafael Pharmaceuticals
Rafael Pharmaceuticals is a provider of metabolic oncology therapeutics intended to treat cancer patients. The company's metabolic oncology therapeutics applies unique bio-energetic processes specific to cancer and provide altered cancer metabolism directed therapies and novel, first-in-class drugs and drug delivery technologies, enabling patients to get revolutionized cancer treatment.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $35.2M
- Funding stage: M&A
- Last round: Corporate Round (Nov 2016)
- Website: rafaelpharma.com
- Phone: (609) 409 7050
Industries & Categories
Biotechnology, Health Care, Medical, Oncology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/rafael-pharmaceuticals-143636 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.